• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma


52.4600 USD 1.3900 2.58%

As of 16:15:03 ET on 09/22/2014.

Snapshot for Hospira Inc (HSP)

Open: 53.6200 Day's Range: 52.4200 - 53.8200 Volume: 648,946
Previous Close: 53.8500 52wk Range: 38.1100 - 56.7800 1-Yr Rtn: +27.42%

Stock Chart for HSP

No chart data available.
  • HSP:US 52.4600
  • 1D
  • 1M
  • 1Y
Interactive HSP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HSP

Current P/E Ratio (ttm) 28.5934
Estimated P/E(12/2014) 21.8310
Relative P/E vs. SPX 1.5729
Earnings Per Share (USD) (ttm) 1.8347
Est. EPS (USD) (12/2014) 2.4030
Est. PEG Ratio 1.6778
Market Cap (M USD) 8,851.67
Shares Outstanding (M) 168.73
30 Day Average Volume 889,617
Price/Book (mrq) 2.7193
Price/Sale (ttm) 2.0409
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HSP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HSP

Hospira, Inc. is a global pharmaceutical and medication delivery company that develops, manufactures and markets products. The Company's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira products are used by hospitals, clinics, home healthcare providers and long-term care facilities.

F Michael Ball "Mike"Chief Executive OfficerDavid John EndicottPres:Medical Devices
Daphne E JonesSenior VP/CIOBrian J SmithSenior VP/Chief Legal Officer
More Company Profile & Key Executives for HSP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil